This is a must read. [View it in your browser.]( [Divider] [fmn-editor
header.jpg] --------------------------------------------------------------- [The American Antidote for Chinese Lithium?]( [See Why Nevada Lithium Should be on Every Investor's Radar](
--------------------------------------------------------------- February 24, 2022 Dear Reader, We have identified several stocks which are expected to go “Ex-Dividend” very soon. If you purchase a stock on its ex-dividend date or after, you will not receive the next dividend payment. Instead, the seller gets the dividend. If you purchase before the ex-dividend date, you get the dividend. If you sell your stock before the ex-dividend date, you also are selling away your right to the stock dividend. So please keep this in mind. Below is our latest Dividend Report: --------------------------------------------------------------- [Biden Executive Order 14017 Potentially Sending Lithium Stocks Skyrocketing](
White House is scared of our country's lithium supply running out. That's why Biden issued executive order 14017 to figure out how to expand our lithium production. And this is GREAT news for one company who's gobbling up land in the lithium-rich Nevada desert. [See How Order 14017 Could Send This Company Skyrocketing](
--------------------------------------------------------------- [Argo Group International Holdings](
Symbol: [ARGO](
Recent Price: $38.7
Average Analyst Price Target: $51.75 (33.72%)
Market Cap: $1.35B
Expected Ex-Dividend Date: Feb 25 2022
Expected Payment Date: Mar 15 2022
Expected Dividend & Yield: 3.25% Recent Analyst Action: Casey Alexander, analyst at Compass Point, reiterates coverage on [Argo Group International Holdings (ARGO)]( in the Financial sector with a Buy rating and a price target of $43.5 (1 day ago). [TipRanks.com]( also reports that [Argo Group International Holdings]( currently has 2 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $51.75 . The target pricing ranges from a high forecast of $60.00 down to a low forecast of $43.50. [Argo Group International Holdings (ARGO)]( last closing price was $38.7 which would put the average price target at 33.72% upside. Here are 3rd party ratings for [ARGO]( - TipRanks.com: Moderate Buy
- TradingView.com: Sell
- Yahoo! Finance: Bearish Short-Term Outlook
- Barchart.com: Strong sell
- Zacks.com: Strong Sell, Top 31% (76 out of 248)
[Click for chart >>](
-------------------------------------------------------------------------- --------------------------------------------------------------- ["I Will Tell You Exactly Where to Invest"]( Biden administration is ushering in an economic shift that could blindside average Americans. Tune into Chief Investment Strategist Shah Gilani’s brand-new “Buy This, Not That” Session to find out exactly where not to invest – the overblown, debt-ridden names that smart investors should steer clear of. [Go here to watch his critical video now.](
--------------------------------------------------------------- [Bank of NT Butterfield & Son](
Symbol: [NTB](
Recent Price: $38.8
Average Analyst Price Target: $45.25 (16.62%)
Market Cap: $1.94B
Expected Ex-Dividend Date: Feb 25 2022
Expected Payment Date: Mar 14 2022
Expected Dividend & Yield: 4.33% Recent Analyst Action: David Feaster, analyst at Raymond James, reiterates coverage on [Bank of NT Butterfield & Son (NTB)]( in the Financial sector with a Buy rating and a price target of $44 (1 week ago). [TipRanks.com]( also reports that [Bank of NT Butterfield & Son]( currently has 4 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $45.25 . The target pricing ranges from a high forecast of $49.00 down to a low forecast of $41.00. [Bank of NT Butterfield & Son (NTB)]( last closing price was $38.8 which would put the average price target at 16.62% upside. Here are 3rd party ratings for [NTB]( - TipRanks.com: Strong Buy
- TradingView.com: Buy
- Yahoo! Finance: Neutral Short-Term Outlook
- Barchart.com: Strong buy
- Zacks.com: Buy, Top 30% (75 out of 248)
[Click for chart >>](
-------------------------------------------------------------------------- [Brunswick](
Symbol: [BC](
Recent Price: $92.39
Average Analyst Price Target: $119.22 (29.04%)
Market Cap: $7.07B
Expected Ex-Dividend Date: Feb 25 2022
Expected Payment Date: Mar 15 2022
Expected Dividend & Yield: 1.44% Recent Analyst Action: Grace Smalley, analyst at J.P. Morgan, reiterates coverage on [Brunswick (BC)]( in the Consumer Goods sector with a Buy rating and a price target of $125 (2 days ago). [TipRanks.com]( also reports that [Brunswick]( currently has 9 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $119.22 . The target pricing ranges from a high forecast of $135.00 down to a low forecast of $105.00. [Brunswick (BC)]( last closing price was $92.39 which would put the average price target at 29.04% upside. Here are 3rd party ratings for [BC]( - TipRanks.com: Strong Buy
- TradingView.com: Strong Sell
- Yahoo! Finance: Bearish Short-Term Outlook
- Barchart.com: Strong sell
- Zacks.com: Buy, Top 28% (69 out of 248)
[Click for chart >>](
-------------------------------------------------------------------------- --------------------------------------------------------------- [2022's Hottest Penny Stocks [Warning: This List May Surprise You]]( an entire universe of penny stocks, Wall Street doesn’t want people to know about. Why? Because they’re too small to recommend. Even if they are the most innovative, entrepreneurial companies in America today... that could make money for investors, hand over fist… to the tune of 6,486% in just one year… Most investors will never hear about these high-flying stocks from Wall Street. [Continue for the full briefing.](
--------------------------------------------------------------- [Cboe Global Markets](
Symbol: [CBOE](
Recent Price: $114.6
Average Analyst Price Target: $144.50 (26.09%)
Market Cap: $12.22B
Expected Ex-Dividend Date: Feb 25 2022
Expected Payment Date: Mar 15 2022
Expected Dividend & Yield: 1.56% Recent Analyst Action: Brian Bedell, analyst at Deutsche Bank, reiterates coverage on [Cboe Global Markets (CBOE)]( in the Financial sector with a Buy rating and a price target of $143 (6 days ago). [TipRanks.com]( also reports that [Cboe Global Markets]( currently has 6 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $144.50 . The target pricing ranges from a high forecast of $160.00 down to a low forecast of $128.00. [Cboe Global Markets (CBOE)]( last closing price was $114.6 which would put the average price target at 26.09% upside. Here are 3rd party ratings for [CBOE]( - TipRanks.com: Moderate Buy
- TradingView.com: Strong Sell
- Yahoo! Finance: Bearish Short-Term Outlook
- Barchart.com: Strong sell
- Zacks.com: Strong Buy, Top 33% (83 out of 248)
[Click for chart >>](
-------------------------------------------------------------------------- [Assurant](
Symbol: [AIZ](
Recent Price: $163.6
Average Analyst Price Target: $199.00 (21.64%)
Market Cap: $9.02B
Expected Ex-Dividend Date: Feb 25 2022
Expected Payment Date: Mar 21 2022
Expected Dividend & Yield: 1.62% Recent Analyst Action: Thomas McJoynt, analyst at KBW, reiterates coverage on [Assurant (AIZ)]( in the Financial sector with a Buy rating and a price target of $189 (1 week ago). [TipRanks.com]( also reports that [Assurant]( currently has 4 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $199.00 . The target pricing ranges from a high forecast of $210.00 down to a low forecast of $189.00. [Assurant (AIZ)]( last closing price was $163.6 which would put the average price target at 21.64% upside. Here are 3rd party ratings for [AIZ]( - TipRanks.com: Strong Buy
- TradingView.com: Buy
- Yahoo! Finance: Bullish Short-Term Outlook
- Barchart.com: Weak buy
- Zacks.com: Hold, Bottom 26% (183 out of 248)
[Click for chart >>](
-------------------------------------------------------------------------- --------------------------------------------------------------- [Time to move your cash?](
South Sea bubble, the stock market crash of 1929, and the tech bubble of 2000 were all brutal to investors. Famous Investor Jeremy Graham, whose firm manages around $65 billion, believes the coming crash will be just as bad. What if he's right? Are you prepared? [If not, click here and at least get the exact day of the next crash.](
--------------------------------------------------------------- [Chemed](
Symbol: [CHE](
Recent Price: $457.55
Average Analyst Price Target: $610.00 (33.32%)
Market Cap: $7.04B
Expected Ex-Dividend Date: Feb 25 2022
Expected Payment Date: Mar 18 2022
Expected Dividend & Yield: 0.31% Recent Analyst Action: Joanna Gajuk, analyst at Bank of America Securities, reiterates coverage on [Chemed (CHE)]( in the Healthcare sector with a Buy rating and a price target of $610 (1 month ago). [TipRanks.com]( also reports that [Chemed]( currently has 1 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $610.00 . The target pricing ranges from a high forecast of $610.00 down to a low forecast of $610.00. [Chemed (CHE)]( last closing price was $457.55 which would put the average price target at 33.32% upside. Here are 3rd party ratings for [CHE]( - TipRanks.com: Moderate Buy
- TradingView.com: Strong Sell
- Yahoo! Finance: Bearish Short-Term Outlook
- Barchart.com: sell
- Zacks.com: Buy, Bottom 33% (167 out of 248)
[Click for chart >>](
-------------------------------------------------------------------------- [MKS Instruments](
Symbol: [MKSI](
Recent Price: $143.07
Average Analyst Price Target: $200.88 (40.41%)
Market Cap: $7.93B
Expected Ex-Dividend Date: Feb 25 2022
Expected Payment Date: Mar 11 2022
Expected Dividend & Yield: 0.58% Recent Analyst Action: Scott Graham, analyst at Loop Capital Markets, reiterates coverage on [MKS Instruments (MKSI)]( in the Industrial Goods sector with a Buy rating and a price target of $200 (2 days ago). [TipRanks.com]( also reports that [MKS Instruments]( currently has 9 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $200.88 . The target pricing ranges from a high forecast of $256.00 down to a low forecast of $155.00. [MKS Instruments (MKSI)]( last closing price was $143.07 which would put the average price target at 40.41% upside. Here are 3rd party ratings for [MKSI]( - TipRanks.com: Strong Buy
- TradingView.com: Sell
- Yahoo! Finance: Bearish Short-Term Outlook
- Barchart.com: sell
- Zacks.com: Strong Sell, Top 41% (102 out of 248)
[Click for chart >>](
-------------------------------------------------------------------------- --------------------------------------------------------------- [All Electric Commitment From GM, Volkswagen, Could Put Lithium Stock In A Supercycle](
automakers are pledging to go "fully electric" by 2035. NOW is the perfect time to get in on the "EV Revolution." And the best way to potentially do that, is to skip over the overvalued electric vehicle stocks... [And Look At Under-The-Radar Lithium Companies...Like This One](
--------------------------------------------------------------- And there you have it... Keep in mind, if you purchase a stock on its ex-dividend date or after, you will not receive the next dividend payment. Instead, the seller gets the dividend. If you purchase before the ex-dividend date, you get the dividend. If you sell your stock before the ex-dividend date, you also are selling away your right to the stock dividend. If you have questions about specific dividends, you should consult with your financial advisor or visit Investor.gov for more information. [Divider] MarketSectorMovers.com | PO Box 407, Mt. Mourne, NC 28123
This is email was sent to {EMAIL} as part of your free newsletter subscription, [click here to unsubscribe](.
Copyright © 2020 WallStreetSectors.com All rights reserved. This newsletter contains advertisements which are neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this newsletter or email is not provided to any individual with a view toward their individual circumstances. Compensation for advertising constitutes a conflict of interest as to our ability to remain objective in our communication regarding any companies profiled. Because of this conflict, individuals are strongly encouraged to not use this newsletter as the basis for any investment decision. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.